Valproic Acid

APR 8, 2026 · REGULATORY LABEL UPDATE

FDA supplemental approval: Valproic Acid (Labeling)

U.S. Food and Drug Administration

FDA supplemental approval for a labeling change to valproic acid; does not report clinical trial data or efficacy evidence.

MAR 31, 2026 · REGULATORY LABEL UPDATE

FDA supplemental approval: Valproic Acid (Labeling)

U.S. Food and Drug Administration

FDA supplemental approval of labeling for valproic acid syrup; this is a regulatory action record, not a clinical study, and does not contain efficacy or safety trial data.

MAR 31, 2026 · REGULATORY LABEL UPDATE

FDA supplemental approval: Valproic Acid (Labeling)

U.S. Food and Drug Administration

This is an FDA supplemental approval action for valproic acid labeling; it documents a regulatory decision, not clinical trial evidence or efficacy data.

MAR 31, 2026 · REGULATORY LABEL UPDATE

FDA supplemental approval: Valproic Acid (Labeling)

U.S. Food and Drug Administration

FDA supplemental approval for valproic acid labeling change; regulatory action only, no clinical trial data or efficacy evidence provided.

MAR 31, 2026 · REGULATORY LABEL UPDATE

FDA supplemental approval: Stavzor (Labeling)

U.S. Food and Drug Administration

FDA supplemental approval of labeling for Stavzor (valproic acid); no clinical trial data or efficacy claims are presented in this regulatory action record.